Stick With BioXcel Therapeutics Inc (BTAI). The Bull Are Alive And Well
Currently, there are 2.65M common shares owned by the public and among those 2.58M shares have been available to trade. The company’s stock has a 5-day price change of 1.41% and -71.28% over the past three months. BTAI shares are trading -63.89% year to date (YTD), with the 12-month market performance down to -95.93% lower. […]
Now Is A Suitable Moment For A Long-Term Purchase Of BioXcel Therapeutics Inc (NASDAQ: BTAI)
Currently, there are 28.15M common shares owned by the public and among those 20.68M shares have been available to trade. Insiders at the company have transacted a total of 42 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 23 of these insider trades were purchases, […]
BioXcel Therapeutics Inc (BTAI): A Great Stock For Handling Current Market Conditions?
The Vanguard Group, Inc. recently announced the acquisition of new stake in BioXcel Therapeutics Inc (NASDAQ:BTAI). The institutional investor has increased its shareholding in the Healthcare company by 8.54% to 1.16 million shares with purchase of 91600.0 shares. This fresh investment now brings its stake to 3.98% valued currently at $3.43 million. In addition, Columbia […]
